scispace - formally typeset
D

Douglas A. Steeber

Researcher at University of Wisconsin–Milwaukee

Publications -  15
Citations -  2713

Douglas A. Steeber is an academic researcher from University of Wisconsin–Milwaukee. The author has contributed to research in topics: Drug delivery & Micelle. The author has an hindex of 14, co-authored 15 publications receiving 2562 citations.

Papers
More filters
Journal ArticleDOI

Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery

TL;DR: Results suggest that H40-P(LA-DOX)-b-PEG-OH/FA micelles could be a promising nanocarrier with excellent in vivo stability for targeting the drugs to cancer cells and releasing the drug molecules inside the cells by sensing the acidic environment of the endosomal compartments.
Journal ArticleDOI

Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.

TL;DR: In vitro degradation studies revealed that the H40-PLA-b-MPEG/PEG-FA block copolymer hydrolytically degraded into polymer fragments within six weeks indicated that the micelles prepared from this block polymer have great potential as tumor-targeted drug delivery nanocarriers.
Journal ArticleDOI

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

TL;DR: These tumor-targeting multifunctional SPIO/DOX-loaded vesicles will provide excellent in vivo stability, pH-controlled drug release, as well as enhanced MRI contrast, thereby making targeted cancer therapy and diagnosis possible.
Journal ArticleDOI

Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.

TL;DR: Results suggest that Au-P(LA-DOX)-b-PEG-OH/FA NPs could be used as a carrier with pH-triggered drug releasing properties for tumor-targeted drug delivery.